Contrast agents for myocardial perfusion imaging
US8226929B2 · kind B2 · utility
20Cited by
36References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 15, 2008 |
| Grant date | Jul 24, 2012 |
| Priority date | — |
| Expiry date | May 26, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D239/88
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure is directed, in part, to compounds and methods for imaging myocardial perfusion, comprising administering to a patient a contrast agent which comprises a compound that binds MC-1, and an imaging moiety, and scanning the patient using diagnostic imaging.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.